Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
AMT Logo
AMT Growth Score
92
CB Rank
48402
Heat Score
58
AMT develops bioresorbable 3D printed vascular stents.
Founded
obfuscation
PrivateSeries D Daxing, Beijing, China51-100 www.ametcorp.com/
3D Printing
Health Care
Medical
Overview

AMT
Total Funding
obfuscation
Growth Score
92
Heat Score
58

Total Funding
obfuscation
obfuscation
Series D raised
obfuscation
Growth Score92
1 pts
in past quarter
Heat Score 58
23 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About AMT

CB Rank
48402
AMT develops bioresorbable 3D printed vascular stents.
Founded
obfuscation
PrivateSeries D Daxing, Beijing, China51-100 www.ametcorp.com/
3D Printing
Health Care
Medical

Funding Rounds

Series D
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Details

Legal Name Beijing Advanced Medical Technologies, Ltd. Inc
Also Known As 阿迈特, 北京阿迈特医疗器械有限公司, Amaite, Amate Medical
Operating Status Active
Company Type For Profit
About the Company
AMT offers 3D-printed vascular stents intended for the medical field. The company utilizes proprietary 3D multi-axial printing technology to develop coronary and peripheral stents that are fully biodegradable, enabling advancements in the medical 3D printing field.
Phone Number 010-6297-7955
Contact Email Amt@ametcorp.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

EZPo® Stent Positioning System
A stent positioning system made of nitinol that assists in precise placement of stents at the aortic-coronary ostium by clearly showing coronary artery openings during implantation.
AMSorb® Fully Bioresorbable Coronary Drug-Eluting Stent
A 3D printed fully bioresorbable coronary stent that delivers sirolimus to prevent restenosis and gradually degrades within the body after implantation.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 7
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series D - AMT Logo
Series D - AMT
3
obfuscation
Zhejiang Life Science and TechnologySeries D
obfuscation
Series D - AMT Logo
Series D - AMT
3
obfuscation
Zhejiang Life Science and TechnologySeries D
obfuscation
Series D - AMT Logo
Series D - AMT
3
obfuscation
Zhejiang Life Science and TechnologySeries D
obfuscation
Series D - AMT Logo
Series D - AMT
3
obfuscation
Zhejiang Life Science and TechnologySeries D
obfuscation
Series D - AMT Logo
Series D - AMT
3
obfuscation
Zhejiang Life Science and TechnologySeries D

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 7
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series D - AMT Logo
Series D - AMT
3
obfuscation
Zhejiang Life Science and TechnologySeries D
obfuscation
Series D - AMT Logo
Series D - AMT
3
obfuscation
Zhejiang Life Science and TechnologySeries D
obfuscation
Series D - AMT Logo
Series D - AMT
3
obfuscation
Zhejiang Life Science and TechnologySeries D
obfuscation
Series D - AMT Logo
Series D - AMT
3
obfuscation
Zhejiang Life Science and TechnologySeries D
obfuscation
Series D - AMT Logo
Series D - AMT
3
obfuscation
Zhejiang Life Science and TechnologySeries D

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 51-100
News
Technology
View Tech Report

Monthly Web Visits

5,580
1,069.81%
 in past month

Active Website Tech Count

7AMT is actively using 7 technologies for its website, according to BuiltWith. These include Euro, CommonCrawl Top 10m, and  Pound Sterling.

Total IP

9The intellectual property of AMT includes 7 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, AMT has registered 2 trademarks with the most popular class being 'Medical apparatus and instruments', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is AMT's headquarters? AMT is located in Daxing, Beijing, China.Who invested in AMT? AMT has 12 investors including Zhejiang Life Science and Technology and  Global Hedge Fund Management.When was the last funding round for AMT? AMT closed its last funding round on
obfuscation
from a Series D round.Who are AMT's competitors? Alternatives and possible competitors to AMT may include Yinyi Biotech, Endovastec, and  MicroPort (Shanghai).How much funding has AMT raised to date? AMT has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3f9296f 1)
|